Korro Bio, Inc. ( KRRO) - Key Metrics
KRRO Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$1.07 | -$0.96 | -$0.97 |
| 2026Q1 | $0 | -$1.69 | -$1.39 | -$1.39 |
| 2025Q4 | $0.14 | -$5.33 | -$1.88 | -$1.89 |
| 2025Q3 | $0.12 | -$1.92 | -$1.83 | -$1.85 |
| 2025Q2 | $0.16 | -$2.74 | -$2.05 | -$2.06 |
KRRO Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -3.08 |
| 2026Q1 | 0% | -1.67 |
| 2025Q4 | 0% | -0.38 |
| 2025Q3 | 0% | -6.24 |
| 2025Q2 | 0% | -1.14 |
KRRO
Price: $13.18
52 week price:
Earnings Per Share: -9.76 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 193.5 million